Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Etanercept 25mg/0.5ml inj pre-filled disposable devices
1001030D0AAAGAG
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | 2 |
|
Etanercept 50mg/1ml inj pre-filled disposable devices
1001030D0AAAEAE
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | 1 |
|
Etanercept 50mg/1ml inj pre-filled syringes
1001030D0AAACAC
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | 1 |
|
Etanercept 10mg inj vials
1001030D0AAAFAF
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Etanercept 25mg inj vials
1001030D0AAAAAA
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Etanercept 25mg/0.5ml inj pre-filled syringes
1001030D0AAADAD
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | No data available |
|
Etanercept 50mg inj vials
1001030D0AAABAB
|
Etanercept | Etanercept | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.